Statements (33)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:affects |
blood pressure
|
| gptkbp:approvalYear |
2002
|
| gptkbp:ATCCode |
gptkb:C09CA08
|
| gptkbp:cause |
renal impairment
hyperkalemia |
| gptkbp:contraindication |
pregnancy
hypersensitivity to olmesartan |
| gptkbp:drugClass |
angiotensin II receptor blocker
|
| gptkbp:eliminationHalfLife |
13 hours
|
| gptkbp:form |
gptkb:tablet
|
| gptkbp:genericAvailable |
yes
|
| gptkbp:genericName |
gptkb:olmesartan_medoxomil
|
| https://www.w3.org/2000/01/rdf-schema#label |
Benicar
|
| gptkbp:interactsWith |
gptkb:NSAIDs
lithium potassium-sparing diuretics |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Daiichi_Sankyo
|
| gptkbp:marketedIn |
gptkb:Europe
gptkb:United_States |
| gptkbp:mechanismOfAction |
blocks angiotensin II receptor type 1
|
| gptkbp:patentExpired |
2016
|
| gptkbp:pregnancyCategory |
D
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
diarrhea
dizziness headache sprue-like enteropathy |
| gptkbp:usedFor |
hypertension
|
| gptkbp:bfsParent |
gptkb:olmesartan
gptkb:Olmesartan |
| gptkbp:bfsLayer |
7
|